Acorda's $525 million spend boosts its Parkinson's fight
October 23, 2014 at 14:51 PM EDT
Acorda Therapeutics Inc. said it has completed its $525 million purchase of Chelsea, Mass.-based Civitas Therapeutics and obtained global rights to the company's treatment for Parkinson's disease...
